Advertisement

Topics

Friedreich's Ataxia Treatment Receives Orphan Drug Designation

10:28 EDT 22 Aug 2017 | PharmPro

Jupiter Orphan Therapeutics receives Orphan Drug designation for its trans-resveratrol product Jotrol for treatment of Friedreich's Ataxia. It is a rare inherited disease that causes damage to the nervous system as well as diminished mobility.
Contributed Author: 
Jupiter Orphan Therapeutics, Inc.

Original Article: Friedreich's Ataxia Treatment Receives Orphan Drug Designation

NEXT ARTICLE

More From BioPortfolio on "Friedreich's Ataxia Treatment Receives Orphan Drug Designation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...